Benefits and Pitfalls of Change From Rome III to Rome IV Criteria for Irritable Bowel Syndrome and Fecal Incontinence
- PMID: 31606457
- DOI: 10.1016/j.cgh.2019.10.004
Benefits and Pitfalls of Change From Rome III to Rome IV Criteria for Irritable Bowel Syndrome and Fecal Incontinence
Comment on
-
Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria.Clin Gastroenterol Hepatol. 2020 Feb;18(2):392-398.e2. doi: 10.1016/j.cgh.2019.05.037. Epub 2019 May 31. Clin Gastroenterol Hepatol. 2020. PMID: 31154027
-
Fecal Incontinence Diagnosed by the Rome IV Criteria in the United States, Canada, and the United Kingdom.Clin Gastroenterol Hepatol. 2020 Feb;18(2):385-391. doi: 10.1016/j.cgh.2019.05.040. Epub 2019 May 30. Clin Gastroenterol Hepatol. 2020. PMID: 31154029
-
Similarities in Clinical and Psychosocial Characteristics of Functional Diarrhea and Irritable Bowel Syndrome With Diarrhea.Clin Gastroenterol Hepatol. 2020 Feb;18(2):399-405.e1. doi: 10.1016/j.cgh.2019.08.020. Epub 2019 Aug 20. Clin Gastroenterol Hepatol. 2020. PMID: 31442602 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
